We believe great partnerships create great possibilities and are inspired by our partners
As a global biopharmaceutical company, we leverage our agility, R&D capabilities and global footprint to develop valuable business partnerships that fuel tomorrow’s breakthrough discoveries across our three therapeutic areas: Oncology, Rare Disease and Neuroscience. External innovation is at the heart of our strategy. We believe in the expertise of our partners and value the opportunity to collaborate, bringing our skills, experience and global reach to accelerate innovation to bring new medicines to patients.
Exclusively sourcing our pipeline through external innovation, we have no internal competing pipeline as we recognize the best science is delivered in biotech and academic institutions. We are proud our team comprises talents attracted from Pharma, biotech and academia, to drive shared success through creative collaborations.
At Ipsen, we believe great partnerships create great possibilities. Data is just the beginning; we go beyond this to translate the clinical benefit into true patient impact. We focus on how one patient will have an enhanced experience because of each innovation and unite expertise to deliver this.
Meet Christelle, EVP and Head of R&D and find out how together we can transfer a molecule into a medicine.
Meet David, SVP, Head of Research and External Innovation and find out how together we can accelerate.
Dedicated to our partners
Meet Masha, Director, Partnering, and hear how Ipsen builds a dedicated team for each program to deliver the best medicine to patients.
Contact the partnering team
At Ipsen, entering partnerships is always personal. Our team is committed to success and has the expertise to deliver it. Contact us to see how together, we can accelerate innovation for patients.
Pipeline
Our robust development pipeline, backed by our expertise and external-innovation strategy, supports patients’ health outcomes across Oncology, Rare Disease and Neuroscience.
Learn more
